Biomarkers
Biomarkers, short for biological markers, are measurable indicators of some biological state or condition, and they play a critical role in both medical research and clinical practice. They are typically used to objectively measure and evaluate physiological processes, pathological states, or pharmacological responses to a therapeutic intervention. Biomarkers can be found in various bodily fluids or tissues and can take many forms, including genes, enzymes, hormones, and antibodies. Their utility spans a wide range of applications, such as diagnosing diseases, monitoring disease progression, predicting treatment response, and identifying individuals at risk for particular conditions. The development and validation of biomarkers are subject to rigorous scientific research, ensuring their reliability and effectiveness in clinical settings. Advances in technology and bioinformatics have greatly enhanced the discovery and utilization of biomarkers, making them increasingly integral to personalized medicine, where treatment and prevention strategies are tailored to individual patients based on their unique biomarker profiles.
Biomarkers
Latest Posts
-
Bioelectrical Impedance Analysis For Monitoring Muscle Health
Researchers at the University of Tsukuba utilized bioelectrical impedance analysis (BIA) to measure adult muscle health, revealing significant correlations between phase angle and muscle contractile properties. This non-invasive method, vital in assessing the health of an aging…
-
Link Between Cellular Metabolism and Depression Uncovered by UC San Diego Study
The University of California San Diego School of Medicine researchers conducted a study that establishes a possible link between cellular metabolism and depression. The research revealed that individuals with depression and suicidal thoughts have specific detectable compounds…
-
Link Between Early Stress, Psychiatric Disorders, and Cognitive Decline: A Penn State Study
A recent study led by the Penn State Center for Healthy Aging investigates the relationship between early life adversity/stress, psychiatric disorders, and the decline in neurocognitive abilities in adulthood, focusing on the role of epigenetic age acceleration…
-
Revolutionizing Alzheimer’s Early Detection: Utilizing Machine Learning Brain Age Prediction Model With FLAIR MRI images
Researchers have made a significant breakthrough in the early detection of Alzheimer’s disease, leveraging the power of brain imaging and machine learning. In a recent study, scientists developed a novel approach using brain age prediction models derived…
-
Revolutionizing Kidney Health Monitoring with Retinal 3D Eye Scans
Recent research has revealed that 3D eye scans, specifically of the retina, can provide critical insights into kidney health. Using highly magnified retinal 3d images obtained by optical coherence tomography, researchers have discovered a non-invasive method to…
-
UT Dallas Researchers Use Machine Learning to Predict Cognitive Health from Brain Biomarkers
Researchers from the Center for BrainHealth at The University of Texas at Dallas trained a machine learning model to forecast changes in cognitive brain health using neural biomarkers from the brain’s blood flow response. The key focus…
-
Revolutionizing Breast Cancer Prognosis with Novel Digital Biomarker Histomic Prognostic Signature(HiPS): A New AI-Driven Approach
The Northwestern Medicine study introduces a novel digital biomarker, the Histomic Prognostic Signature (HiPS), using a new deep learning-based AI tool designed to improve breast cancer prognosis. Traditional methods, like the Nottingham criteria used by pathologists, focus…
-
USC Study Reveals Two Metabolites Enhance Prediabetes Prediction in Latino Youth Beyond Traditional Risk Factors
Researchers from the Keck School of Medicine of the University of Southern California, funded by the National Institutes of Health, conducted a study focusing on prediabetes in young Latino people. The study found that adding two specific…
-
Using Epigenetic Factors UCLA Cancer Researchers Develop AI Model to Predict Patient Outcomes in Multiple Cancer Types
Researchers at UCLA’s Jonsson Comprehensive Cancer Center developed an AI model that predicts patient outcomes in various cancer types using epigenetic factors (epifactors). This model categorizes cancers into distinct groups based on the gene expression patterns of…
-
Uppsala University Develops CVD-21: A New Instrument for Enhanced Cardiovascular Disease Risk Assessment
Researchers at Uppsala University present the development of the CVD-21 tool, a decision-support instrument for cardiovascular disease (CVD) treatment. The instrument’s development involved analyzing 368 proteins in blood samples from over 10,000 patients in international studies on…
You must be logged in to post a comment.